Skip to main content
    T

    The Clorox Company (CLX)

    Official site

    CONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE

    $110.17
    +0.71 (+0.65%)

    Market Cap: $13.26B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    The Clorox Company (CLX) Earnings: Report Dates and Results

    Updated Nov 2, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    The Clorox Company (CLX) is expected to report earnings on Feb 1, 2027. In the quarter ended Sep 30, 2026, The Clorox Company reported EPS of $1.55, above the $0.97 estimate. It beat the EPS estimate in 6 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    80%(32/40)
    Avg Surprise
    +21.56%
    Streak
    3 Q

    Upcoming Estimates

    Reports Feb 1, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$0.98
    Range$0.87 - $1.05
    15 analysts
    EPS Revisions
    4
    6
    30d
    EPS Estimate DriftChange to current
    90d ago$1.37-28.1%
    60d ago$1.37-28.1%
    30d ago$1.34-26.6%
    7d ago$1.34-26.3%
    Current$0.98
    Revenue Consensus
    $1.87B
    Range$1.85B - $1.89B
    12 analysts
    Reports Apr 28, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$1.49
    Range$1.39 - $1.60
    15 analysts
    EPS Revisions
    2
    7
    30d
    EPS Estimate DriftChange to current
    90d ago$1.59-6.0%
    60d ago$1.59-6.0%
    30d ago$1.58-5.5%
    7d ago$1.56-4.5%
    Current$1.49
    Revenue Consensus
    $1.89B
    Range$1.84B - $1.90B
    11 analysts

    Next Report

    CLX has an expected report date of Feb 1, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 29.5% below the $1.39 reported for the quarter ended Dec 31, 2025.

    CLX Earnings Call

    The latest CLX earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, CLX beat 32, missed 7 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $1.91B, up 33.6% from $1.43B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$1.55$0.97$0.87 - $1.20+59.79%Beat+82.4%151 up, 9 downNov 2, 2026$1.91B
    Jun 30, 2026$1.66$1.64$1.59 - $1.71+1.22%Beat-42.2%140 up, 2 downAug 3, 2026$1.95B
    Mar 31, 2026$1.64$1.54$1.33 - $1.67+6.49%Beat+13.1%161 up, 9 downApr 30, 2026$1.67B
    Dec 31, 2025$1.39$1.43$1.33 - $1.51-2.80%Miss-10.3%140 up, 3 downFeb 3, 2026$1.67B
    Sep 30, 2025$0.85$0.78$0.60 - $0.96+8.97%Beat-54.3%141 up, 8 downNov 3, 2025$1.43B
    Jun 30, 2025$2.87$2.21$2.07 - $2.46+29.86%Beat+57.7%153 up, 7 downJul 31, 2025$1.99B
    Mar 31, 2025$1.45$1.56$1.48 - $1.64-7.05%Miss-15.2%152 up, 9 downMay 5, 2025$1.67B
    Dec 31, 2024$1.55$1.40$1.24 - $1.57+10.71%Beat-28.2%145 up, 2 downFeb 3, 2025$1.69B
    Sep 30, 2024$1.86$1.39$1.28 - $1.57+33.81%Beat+279.6%146 up, 1 downOct 30, 2024$1.76B
    Jun 30, 2024$1.82$1.56$1.42 - $1.64+16.67%Beat+9.0%153 up, 0 downAug 1, 2024$1.90B
    Mar 31, 2024$1.71$1.37$1.23 - $1.63+24.82%Beat+13.2%140 up, 0 downApr 30, 2024$1.81B
    Dec 31, 2023$2.16$1.10$0.80 - $1.29+96.36%Beat+120.4%153 up, 1 downFeb 1, 2024$1.99B
    Sep 30, 2023$0.49-$0.23-$0.40 - -$0.03+313.04%Beat-47.3%130 up, 0 downNov 1, 2023$1.39B
    Jun 30, 2023$1.67$1.18$1.03 - $1.38+41.53%Beat+79.6%144 up, 0 downAug 2, 2023$2.02B
    Mar 31, 2023$1.51$1.22$1.02 - $1.41+23.77%Beat+15.3%166 up, 0 downMay 2, 2023$1.92B
    Dec 31, 2022$0.98$0.66$0.46 - $0.81+48.48%Beat+48.5%163 up, 1 downFeb 2, 2023$1.72B
    Sep 30, 2022$0.93$0.78$0.53 - $0.89+19.23%Beat-23.1%166 up, 1 downNov 1, 2022$1.74B
    Jun 30, 2022$0.93$0.93$0.80 - $1.020.00%In line-2.1%132 up, 4 downAug 3, 2022$1.80B
    Mar 31, 2022$1.31$0.96$0.78 - $1.12+36.46%Beat-19.1%131 up, 1 downMay 2, 2022$1.81B
    Dec 31, 2021$0.66$0.85$0.69 - $1.03-22.35%Miss-67.5%154 up, 0 downFeb 3, 2022$1.69B
    Sep 30, 2021$1.21$1.02$0.80 - $1.15+18.63%Beat-62.4%150 up, 0 downNov 1, 2021$1.81B
    Jun 30, 2021$0.95$1.31$1.19 - $1.97-27.48%Miss-60.6%15N/AAug 3, 2021$1.80B
    Mar 31, 2021$1.62$1.46$1.29 - $1.80+10.96%Beat-14.3%14N/AApr 30, 2021$1.78B
    Dec 31, 2020$2.03$1.75$1.59 - $2.01+16.00%Beat+39.0%15N/AFeb 4, 2021$1.84B
    Sep 30, 2020$3.22$2.25$2.06 - $2.59+43.11%Beat+102.5%13N/ANov 2, 2020$1.92B
    Jun 30, 2020$2.41$1.99$1.87 - $2.08+21.11%Beat+28.2%13N/AAug 3, 2020$1.98B
    Mar 31, 2020$1.89$1.63$1.38 - $1.98+15.95%Beat+31.3%13N/AMay 1, 2020$1.78B
    Dec 31, 2019$1.46$1.33$1.25 - $1.35+9.77%Beat+4.3%14N/AFeb 4, 2020$1.45B
    Sep 30, 2019$1.59$1.54$1.48 - $1.62+3.25%Beat-1.9%15N/AOct 31, 2019$1.51B
    Jun 30, 2019$1.88$1.84$1.80 - $1.86+2.17%Beat+13.3%15N/AAug 1, 2019$1.63B
    Mar 31, 2019$1.44$1.47$1.39 - $1.51-2.04%Miss+5.1%17N/AMay 1, 2019$1.55B
    Dec 31, 2018$1.40$1.31$1.23 - $1.41+6.87%Beat+20.7%16N/AFeb 4, 2019$1.47B
    Sep 30, 2018$1.62$1.59$1.48 - $1.66+1.89%Beat+11.0%16N/AOct 31, 2018$1.56B
    Jun 30, 2018$1.66$1.59$1.52 - $1.62+4.40%Beat+8.5%16N/AAug 2, 2018$1.69B
    Mar 31, 2018$1.37$1.31$1.28 - $1.34+4.58%Beat+4.6%14N/AMay 2, 2018$1.52B
    Dec 31, 2017$1.16$1.23$1.18 - $1.26-5.69%Miss+1.8%16N/AFeb 2, 2018$1.42B
    Sep 30, 2017$1.46$1.42$1.38 - $1.45+2.82%Beat+7.4%14N/ANov 1, 2017$1.50B
    Jun 30, 2017$1.53$1.49$1.46 - $1.54+2.68%Beat+21.4%17N/AAug 3, 2017$1.65B
    Mar 31, 2017$1.31$1.30N/A+0.77%Beat+8.3%N/AN/AMay 3, 2017$1.48B
    Dec 31, 2016$1.14$1.22N/A-6.56%Miss0.0%N/AN/AFeb 3, 2017$1.41B
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Jun 30, 2026 was $5.54, down 28.3% from the year before. It was $5.34 for the year ended Jun 30, 2017, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Jun 30, 2026$5.54-28.3%
    Jun 30, 2025$7.73+25.1%
    Jun 30, 2024$6.18+21.4%
    Jun 30, 2023$5.09+23.8%
    Jun 30, 2022$4.11-47.4%
    Jun 30, 2021$7.82+6.4%
    Jun 30, 2020$7.35+15.9%
    Jun 30, 2019$6.34+12.2%
    Jun 30, 2018$5.65+5.8%
    Jun 30, 2017$5.34N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 5,400 words across 15 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20265,43515
    2026Q2Jun 30, 20269,53117
    2026Q1Mar 31, 20267,46014
    2025Q4Dec 31, 20259,26517
    2025Q3Sep 30, 20258,91717
    2025Q2Jun 30, 20253,39820
    2025Q1Mar 31, 20258,87918
    2024Q4Dec 31, 202411,10518

    2026Q3 Earnings Call

    Opening remarks

    Lisah Burhan Vice President, Investor Relations Thank you. Good afternoon, and thank you for joining us. On the call with me today are Linda Rendle, our Chair and CEO; and Luc Bellet, our CFO. Please note that our earnings release and prepared remarks are available on our website at thecloroxcompany.com. Linda will share a few opening comments, and then we'll take your questions. During this call, we may make forward-looking statements, including about our fiscal 2026 outlook. These statements are based on management's current expectations but may differ from actual results or outcomes. In addition, we may refer to certain non-GAAP financial measures. Please refer to the forward-looking statements section, which identifies various factors that could affect such forward-looking statements, which has been filed with the SEC. In addition, please refer to the non-GAAP financial information section of our earnings release and the supplemental financial schedule in the Investor Relations section of our website for reconciliation of non-GAAP financial measures to the most directly comparable GAAP measures. I'll now turn it over to Linda.

    Linda Rendle Chair and CEO Thank you for joining us today. As we approached fiscal year 2026, we knew it would take a disciplined, phased approach. In the front half of the year, we intentionally focused on implementing and stabilizing our new ERP. That work was foundational to strengthening how we operate, even though we knew it would create some near-term disruption. As we moved into the back half, our focus turned to rebuilding momentum, getting innovation to shelf and sharpening execution. That sequencing is still the right one and it remains central to our plan. That said, the pace of improvement has been slower than we expected in some businesses and as a result, our third quarter results were mixed and fell short of our expectations. We continue to make progress on market share across much of the portfolio, but more gradually than we anticipated in certain categories. Gross margin also came in below expectations, driven by higher-than-expected supply chain costs and delayed cost savings as we deliberately prioritized stabilizing the ERP. Even with those challenges, we remain confident in the path forward. With the ERP implementation now complete, we're better positioned to convert our innovation, investments and distribution gains into value superiority for our brands and stronger results. Our focus is squarely on execution, delivering the fundamentals, accelerating innovation performance and finishing the year with momentum as we set up for fiscal year 2027. With that, Luc and I are happy to take your questions.

    Operator Operator And our first question comes from Peter Grom with UBS Financial.

    Peter Grom Analyst, UBS Financial I was hoping to start just on the top line trajectory. You touched on some of the macro pressures.

    Frequently Asked Questions About CLX

    When is The Clorox Company's next earnings date?

    The Clorox Company's next earnings report is expected for Feb 1, 2027.

    Did CLX beat earnings estimates last quarter?

    Yes. The Clorox Company reported EPS of $1.55 for the quarter ended Sep 30, 2026, above the $0.97 estimate, a 59.79% surprise.

    What EPS do analysts expect from CLX next quarter?

    The consensus EPS estimate for The Clorox Company for the quarter ending Dec 31, 2026 is $0.98 from 15 analysts, with estimates from $0.87 to $1.05.

    How often does CLX beat earnings estimates?

    The Clorox Company beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +13.40%.